22
Acute Kidney Injury after Cardiopulmonary Bypass Catherine Krawczeski, MD Associate Professor of Pediatrics University of Cincinnati College of Medicine Cardiac Intensive Care Co-Director, Center for Acute Care Nephrology The Heart Institute Cincinnati Children’s Hospital Medical Center

Acute Kidney Injury after Cardiopulmonary Bypass Catherine Krawczeski, MD Associate Professor of Pediatrics University of Cincinnati College of Medicine

Embed Size (px)

Citation preview

Acute Kidney Injury after Cardiopulmonary Bypass

Catherine Krawczeski, MD

Associate Professor of Pediatrics

University of Cincinnati College of Medicine

Cardiac Intensive Care

Co-Director, Center for Acute Care Nephrology

The Heart Institute

Cincinnati Children’s Hospital Medical Center

HEART

KIDNE

Y

Why Study AKI after Cardiac Surgery?

• Over a million adults and 25,000 children undergo cardiac surgery with CPB in the US each year

• Acute Kidney Injury (AKI) occurs in 30-40% of adult and pediatric patients after CPB

• Pediatric patients- particularly infants- may be especially vulnerable

• Planned period of renal ischemia

• Pediatric patients free of other “co-morbidities” that may confound therapies

Impact of CS-AKI

• Independently associated with:

Increased mortality Increased length of postoperative ventilationLonger hospital and ICU lengths of stayIncreased hospital costsWorse ventricular function on discharge echoLower long-term quality of life

430 infants <90d undergoing CPB-- 52% developed postoperative AKI

Long-term effects of CS-AKI in pediatrics

• Growth (height) impairment

• Increased health care utilization

• Trend towards higher long-term mortality

• Unknown long-term risk of CKD

Morgan et al, J Pediatr, 2012 Aug 7 [Epub] Brown et al, Ann Thorac Surg, 2010;90:1142-1149

Mechanisms of Injury during CPB

• Ischemia/reperfusion injury• Inflammation• Oxidative stress• RBC injury• Coagulopathy• Loss of pulsatile flow• Microembolism• Hypothermia• Altered hemodynamics

Mechanisms of AKI

Devarajan JASN 17:1503-20, 2006

Biochemistry of AKI

Devarajan JASN 17:1503-20, 2006

Risk Factors for CS-AKI

Adult Studies Pediatric Studies All Ages

↓ Pre-op renal fxn

Longer CPB time

Blood transfusion

Adult Studies Pediatric Studies All Ages

Advanced Age ↓ Pre-op renal fxn

African-American ethnicity

Longer CPB time

Increased BMI Blood transfusion

Hypertension

PVD

Diabetes

↓ LV function

Intra-op hypotension

Re-operation

Risk Factors for CS-AKI

Adult Studies Pediatric Studies All Ages

Advanced Age Younger Age ↓ Pre-op renal fxn

African-American ethnicity

DHCA Longer CPB time

Increased BMI Lower Gestational Age Blood transfusion

Hypertension Chromosomal Anomaly

PVD Pre-op Ventilation

Diabetes Cardiac Anatomy

↓ LV function Surgical Complexity

Intra-op hypotension

Re-operation

Risk Factors for CS-AKI

Defining the “At Risk Population”

Several Scoring systems have been developed/studied:

•CICSS (Continuing Improvement in Cardiac Surgery Study)•Cleveland Clinic•STS Bedside Risk•MCSPI (Multicenter study of perioperative ischemia)•AKICS (AKI after Cardiac Surgery)•NNECDSG (Northern New England Cardiovascular Disease Study Group)

Reported AUC’s 0.72-0.84

Huen and Parikh, Ann Thorac Surg 2012;93: 337-47

Genetics and AKI

• Search for genetic polymorphisms the predispose to AKI

• Majority are SNPs associated with gene products that contribute to:

• Proinflammatory state• Increased response to

oxidative stress• Impaired renal vascular

responsiveness

Genetics and AKI

1671 patients

Aorto-coronary surgery•Highest AKI risk (4X greater) with combination AGT 842G + IL-6 -572

Potential Areas for Intervention

Apoptosisinhibitors

Potential Areas for Intervention

Iron

Vasodilators

Apoptosisinhibitors

Ca channelblockers

Anti-oxidants

Iron chelators

ATP donors NOS inhibitors

Currently Available Therapies

Mariscalco et al. Ann Thorac Surg 2011; 92: 1539-47

What’s on the Horizon

• Modification of diagnostic criteria for AKI

• Development of reliable tools to predict who will develop AKI and for early rapid diagnosis

• Therapeutic trials